An Australian stem cell and regenerative medicine company

Scientific Advisors

Cynata engages scientific advisors to provide advice and guidance on the Company’s research and development programs. Cynata seeks advice regularly from one of the Company’s founders, Professor Igor Slukvin. Additionally, Cynata has strong connections with numerous globally recognised experts and key opinion leaders in the fields of cell biology, regenerative medicine and biopharmaceutical development. Relevant experts are called upon to provide advice on an ad hoc basis, depending on the nature of the issues to be discussed.

Professor Igor Slukvin

Igor Slukvin is Professor of Pathology and Laboratory Medicine at the University of Wisconsin-Madison, School of Medicine and Public Health. His research program focuses on development of hematopoietic, vascular and mesenchymal lineages from human pluripotent stem cells. His work identified several novel progenitors for blood, endothelial and mesenchymal stem cells, including mesenchymoangioblasts (MCAs), a common precursor for endothelial and mesenchymal stem cells. Professor Slukvin received his MD and PhD from Kiev Medical University, Ukraine, and completed postdoctoral and medical residency training at the University of Wisconsin. He has published over 70 peer reviewed research papers and serves on several editorial boards. Professor Slukvin holds key patents in the area of haematovascular cell production from human pluripotent stem cells, several of which form the core of the Company’s intellectual property portfolio, and is a co-founder of Cynata and also of Cellular Dynamics International, previously listed on Nasdaq but acquired by FUJIFILM in 2015 for US$307m.